Walvax BioTech Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Walvax BioTech cash flow conversion efficiency. Based on the latest financial reports, Walvax BioTech (300142) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-33.52 Million ≈ $-4.91 Million USD) by net assets (CN¥10.94 Billion ≈ $1.60 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Walvax BioTech (2007–2025)

Cash flow conversion efficiency of Walvax BioTech from 2007 to 2025. This chart illustrates how Walvax BioTech's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Walvax BioTech stock price for real-time trading data and today's change.

Walvax BioTech Cash Flow Conversion Ratio Explained

Walvax BioTech cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Walvax BioTech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Walvax BioTech ranked by their cash flow conversion efficiency. Also see 300142 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Wanda Cinema Line Corp SHE:002739	0.065x
Mobimo Hldg SW:MOBN	0.049x
Colt CZ Group SE PR:COLT	0.008x
Neogen Corporation NASDAQ:NEOG	0.006x
Rocket Internet SE HM:RKET	N/A
Home Product Center Public Company Limited BK:HMPRO	0.023x
Guangdong Create Century Intelligent Equipment Group Corp Ltd SHE:300083	-0.002x
Shenzhen O-Film Tech Co Ltd SHE:002456	-0.026x

Annual Cash Flow Conversion Efficiency for Walvax BioTech (2007–2025)

The table below shows the annual cash flow conversion efficiency of Walvax BioTech from 2007 to 2025. Review 300142 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.81 Billion ≈ $1.44 Billion	CN¥494.37 Million ≈ $72.34 Million	0.050x	-44.07%
2024-12-31	CN¥11.51 Billion ≈ $1.68 Billion	CN¥1.04 Billion ≈ $151.68 Million	0.090x	-9.47%
2023-12-31	CN¥11.40 Billion ≈ $1.67 Billion	CN¥1.13 Billion ≈ $165.91 Million	0.099x	-8.99%
2022-12-31	CN¥10.99 Billion ≈ $1.61 Billion	CN¥1.20 Billion ≈ $175.82 Million	0.109x	+55.00%
2021-12-31	CN¥10.00 Billion ≈ $1.46 Billion	CN¥705.28 Million ≈ $103.20 Million	0.071x	+384.76%
2020-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥114.19 Million ≈ $16.71 Million	0.015x	+32.94%
2019-12-31	CN¥5.67 Billion ≈ $829.11 Million	CN¥62.02 Million ≈ $9.08 Million	0.011x	+188.30%
2018-12-31	CN¥5.26 Billion ≈ $770.02 Million	CN¥-65.23 Million ≈ $-9.54 Million	-0.012x	-335.34%
2017-12-31	CN¥3.56 Billion ≈ $520.57 Million	CN¥-10.13 Million ≈ $-1.48 Million	-0.003x	+88.84%
2016-12-31	CN¥3.52 Billion ≈ $515.62 Million	CN¥-89.94 Million ≈ $-13.16 Million	-0.026x	-11.19%
2015-12-31	CN¥3.02 Billion ≈ $442.47 Million	CN¥-69.41 Million ≈ $-10.16 Million	-0.023x	-11.83%
2014-12-31	CN¥3.21 Billion ≈ $470.01 Million	CN¥-65.93 Million ≈ $-9.65 Million	-0.021x	+50.45%
2013-12-31	CN¥2.94 Billion ≈ $429.99 Million	CN¥-121.73 Million ≈ $-17.81 Million	-0.041x	-267.52%
2012-12-31	CN¥3.17 Billion ≈ $463.81 Million	CN¥78.38 Million ≈ $11.47 Million	0.025x	-27.05%
2011-12-31	CN¥2.71 Billion ≈ $397.06 Million	CN¥91.98 Million ≈ $13.46 Million	0.034x	-0.28%
2010-12-31	CN¥2.55 Billion ≈ $373.28 Million	CN¥86.71 Million ≈ $12.69 Million	0.034x	-92.77%
2009-12-31	CN¥174.69 Million ≈ $25.56 Million	CN¥82.18 Million ≈ $12.03 Million	0.470x	+912.58%
2008-12-31	CN¥98.36 Million ≈ $14.39 Million	CN¥-5.69 Million ≈ $-833.30K	-0.058x	-103.21%
2007-12-31	CN¥17.66 Million ≈ $2.58 Million	CN¥31.85 Million ≈ $4.66 Million	1.804x	--

About Walvax BioTech

SHE:300142 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.55 Billion

CN¥17.42 Billion CNY

Market Cap Rank

#5185 Global

#825 in China

Share Price

CN¥10.89

Change (1 day)

-5.39%

52-Week Range

CN¥10.89 - CN¥16.10

All Time High

CN¥93.63